OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells remains a paramount challenge for the biopharmaceutical industry. Various strategies have been employed maximize antibody titer, comprising process parameter optimization, media optimization, and adoption of perfusion processes. Fine-tuning culture conditions